Calidi Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,504 |
Gross Profit | -427 | -407 | -394 | -393 |
EBITDA | -4,703 | -5,298 | -4,593 | -3,577 |
EBIT | -5,130 | -5,705 | -4,987 | -3,970 |
Net Income | -5,149 | -5,715 | -4,986 | -4,097 |
Net Change In Cash | 0 | 0 | 0 | 1,504 |
Free Cash Flow | -4,265 | -4,937 | -7,138 | -5,428 |
Cash | 10,375 | 5,279 | 10,561 | 9,591 |
Basic Shares | 4,907 | 2,877 | 2,248 | 664 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $45 | $449 |
Gross Profit | -1,535 | -1,256 | -229 | 355 |
EBITDA | -19,727 | -24,195 | -24,998 | -9,450 |
EBIT | -21,262 | -25,451 | -25,258 | -9,606 |
Net Income | -22,143 | -29,216 | -25,427 | -10,933 |
Net Change In Cash | 0 | 0 | 45 | 449 |
Free Cash Flow | -19,710 | -27,568 | -13,642 | -7,980 |
Cash | 9,591 | 2,049 | 372 | 2,137 |
Basic Shares | 664 | 140 | 70 | 238 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.21 |
2025-06-30 | -$1.99 |
2025-03-31 | -$0.18 |
2024-12-31 | -$0.27 |
